5 min listen
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
ratings:
Length:
6 minutes
Released:
Apr 6, 2023
Format:
Podcast episode
Description
In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson’s disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
Released:
Apr 6, 2023
Format:
Podcast episode
Titles in the series (99)
April 2, 2020 Issue Introduction by Neurology Today in 5